Summary

[00:05:37] Drive Medical's background and overview

[00:10:49] Sales trends in POCS
[00:16:07] Difficulty of bringing POCS to commercialization to compete against Inogen
[00:18:39] Sizing the market opportunity for POCS
[00:25:31] B2B aspect of Inogen and POCS
[00:32:34] Manufacturing issues of Inogen
[00:37:11] D2C aspect of Inogen and POCS
[00:42:56] Impact of Covid-19 crisis on POCS sales
[0046:04] Inogen's growth sales over the next years
[00:52:07] Inogen's acquisition of New Aera Tidal Assist Ventilator
[00:56:11] The future of Invacare

DME

Mosaic

[00:04:01-00:04:03] Expert: Columbia Presbyterian Medical Center

[00:04:18-00:04:24] Expert: o obstructive sleep apnea products like CPAP bilevel and things like
that by 2001.
[00:04:55-00:04:59] Expert: I joined Drive Medical on the manufacturing side.
[00:05:39-00:05:40] Expert: Drive Development Health Care
[00:06:39-00:06:55] Expert: Drive was founded in 2000 and it was intended to be a sort of
regional OEM distributor of commodity, bent metal, durable medical equipment products.
Inva care, sunrise, DME, Drive, Clayton Dubilier and Rice, DeVilbiss, Inogen, Philips
Lincare, ArrowCare, Adaptil, ResMed, Apria, Rotech, Colorado American Oxygen and Repair,
1st Class Medical, Advanced Care Medical Services Company, Super Care, New Aera,
Breathe, Hillrom, pride, quantum
[00:07:17-00:07:46] Expert: At the time the industry did not agree with Drives and thought
American-made products would always be China made products. Drive proved them wrong
because the quality was better from China than anyone expected and instead of just having a
benefit on the cost of good side and getting maybe one order and then a crutch breaking and
never buying again the product stood the test of time.
[00:11:34-00:11:37] Expert: portable oxygen concentrators
[00:21:29-00:21:35] Analyst: ome oxygen market right now. Where do you think that penetration
level will go over time?
[00:33:13-00:33:30] Analyst: ctually before we go to the direct to consumer side. How do you
think competitive bidding this time around is impacting the oxygen business and pocs either now
or after the rates come out later this ye
[00:52:19-00:52:30] Expert: idal Assist Ventilator. That was, I think, the biggest mistake that
Inogen has ever made and they've made some big mistakes, but do you want to delve into that
at all?
[00:56:28-00:56:37] Analyst: be your quick perspective as somebody who competes in the DME
manufacturing business. What is the future for Invacare at this point?